Esophageal Cancer Clinical Trial

Esophageal Cancer Multimodal Prehabilitation Study

Summary

The goal of this research study is to investigate the feasibility of implementing a prehabilitation program that aims to improve a patient's physical, nutritional, and sleep health before surgery in an older, at-risk group with esophageal cancer.

View Full Description

Full Description

This research study is to test whether a novel, 4-week surgical multimodal prehabilitation protocol is feasible in at-risk older adult patients who have previously undergone neoadjuvant chemotherapy or radiotherapy and are scheduled for surgical removal of esophageal cancer.

Research study procedures include screening for eligibility, clinic visits, questionnaires, blood tests, and Computed Tomography (CT) scans.

Participation in this research study is expected to last 7 months.

It is expected about 30 patients will participate in this study.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

65 years of age and over
Adult male or non-pregnant female volunteers
Completed neoadjuvant chemotherapy or radiotherapy for esophageal cancer
At least four weeks to esophageal cancer surgery
Without skin conditions that preclude wearing sensors
Able to speak English and consent

Exclusion Criteria:

Participants in any other interventional study that may bias results or limit study adherence during our study
Dietary restrictions that prevent consumption of nutritional supplements
Women who are pregnant, nursing, or at risk of becoming pregnant
Profound physical disability (for example, quadriplegia) that precludes participation in any aerobic or strength training.

Study is for people with:

Esophageal Cancer

Estimated Enrollment:

30

Study ID:

NCT06027515

Recruitment Status:

Recruiting

Sponsor:

Massachusetts General Hospital

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Massachusetts General Hospital
Boston Massachusetts, 02215, United States More Info
Hassan Dashti, PhD
Contact
617-726-9132
[email protected]
Federico Ciardi, MBBS
Sub-Investigator

How clear is this clinincal trial information?

Study is for people with:

Esophageal Cancer

Estimated Enrollment:

30

Study ID:

NCT06027515

Recruitment Status:

Recruiting

Sponsor:


Massachusetts General Hospital

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.